The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
The Role of Myc-Induced Protein Synthesis in Cancer
Open accessAbstract
Deregulation in different steps of translational control is an emerging mechanism for cancer formation. One example of an oncogene with a direct role in control of translation is the Myc transcription factor. Myc directly increases protein synthesis rates by controlling the expression of multiple components of the protein synthetic machinery, including ribosomal proteins and initiation factors of translation, Pol III and rDNA. However, the contribution of Myc-dependent increases in protein synthesis toward the multistep process leading to cancer has remained unknown. Recent evidence strongly suggests that Myc oncogenic signaling may monopolize the translational machinery to elicit cooperative effects on cell growth, cell cycle progression, and genome instability as a mechanism for cancer initiation. Moreover, new genetic tools to restore aberrant increases in protein synthesis control are now available, which should enable the dissection of important mechanisms in cancer that rely on the translational machinery. [Cancer Res 2009;69(23):8839–43]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, MYC is a well-established regulator of ribosome biogenesis and protein translation, including cap-dependent translation, and can rewire translational control in tumor cells when it is overexpressed (29–31).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,417
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,111
Self-citationColler, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
How Common Are Extraribosomal Functions of Ribosomal Proteins?
Warner, J. R., & McIntosh, K. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.006 · Cited by 735
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 659
Drosophila myc Regulates Cellular Growth during Development
Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., & Gallant, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81512-3 · Cited by 648
dMyc Transforms Cells into Super-Competitors
Moreno, E., & Basler, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00262-4 · Cited by 597
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C.-N., Fátyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 507
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A. D., Zollo, O., Costa, M. J. D. C., Kondrashov, N., Rego, E. M., Rao, P. H., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 454
Self-citationPhenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 443
Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development
Grewal, S., Li, L., Orian, A., Eisenman, R. N., & Edgar, B. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1223 · Cited by 387
c-Myc enhances protein synthesis and cell size during B lymphocyte development
Iritani, B. M., & Eisenman, R. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13180 · Cited by 364
C-Myc 5′ untranslated region contains an internal ribosome entry segment
Stoneley, M., Paulin, F., Quesne, J. P. C. L., Chappell, S. A., & Willis, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201763 · Cited by 333
Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1
Pérez‐Roger, I., Kim, S., Griffiths, B. L., Sewing, A., & Land, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5310 · Cited by 331
Identification and Characterization of a Novel Cell Cycle–Regulated Internal Ribosome Entry Site
Cornelis, S., Bruynooghe, Y., Denecker, G., Huffel, S. V., Tinton, S. A., & Beyaert, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80239-7 · Cited by 326
The transcriptional program of a human B cell line in response to Myc
Schuhmacher, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.2.397 · Cited by 306
Ribosomal protein L24 defect in Belly spot and tail (Bst), a mouse Minute
Oliver, E. R., Saunders, T. L., Tarlé, S. A., & Glaser, T. (2004) · Development · doi:10.1242/dev.01268 · Cited by 288
Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N., & Schmidt, E. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7358 · Cited by 287
Identification of c-myc responsive genes using rat cDNA microarray.
Guo, Q., Malek, R. L., Kim, H., Chiao, C., He, M., Ruffy, M., Sanka, K., Lee, N. H., Dang, C. V., & Liu, E. T. (2000) · PubMed · Cited by 265
14-3-3σ controls mitotic translation to facilitate cytokinesis
Wilker, E., van Vugt, M. A. T. M., Artim, S. C., Huang, P. H., Petersen, C. P., Reinhardt, H. C., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., et al. (2007) · Nature · doi:10.1038/nature05584 · Cited by 217
Cell cycle activation by c-myc in a Burkitt lymphoma model cell line
Pajic, A., Spitkovsky, D., Christoph, B., Kempkes, B., Schuhmacher, M., Staege, M. S., Brielmeier, M., Ellwart, J. W., Kohlhuber, F., Bornkamm, G. W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6 · Cited by 206
MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation
Poortinga, G., Hannan, K., Snelling, H., Walkley, C. R., Jenkins, A., Sharkey, K., Wall, M., Brandenburger, Y., Palatsides, M., Pearson, R., et al. (2004) · EMBO Journal · doi:10.1038/sj.emboj.7600335 · Cited by 198
Kim, S., Li, Q., Dang, C. V., & Lee, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200372597 · Cited by 187
A role for c-Myc in the regulation of ribosomal RNA processing
Schlosser, I. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg794 · Cited by 183
Cell-cycle-dependent translational control.
Pyronnet, S., & Sonenberg, N. (2001) · Current Opinion in Genetics and Development · doi:10.1016/s0959-437x(00)00150-7 · Cited by 176
Anderson, S. J., Lauritsen, J. P. H., Hartman, M. G., Foushee, A. M. D., Lefebvre, J. M., Shinton, S. A., Gerhardt, B., Hardy, R. R., Oravecz, T., & Wiest, D. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.012 · Cited by 173
Panić, L., Tamarut, S., Sticker-Jantscheff, M., Barkić, M., Solter, D., Uzelac, M., Grabušić, K., & Volarević, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00751-06 · Cited by 135
The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation
Petretti, C., Savoian, M. S., Montembault, É., Glover, D. M., Prigent, C., & Giet, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400639 · Cited by 134
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis
Greasley, P. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.446 · Cited by 126
Iritani, B. M., Delrow, J. J., Grandori, C., Gomez, I. G., Klacking, M., Carlos, L. S., & Eisenman, R. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf492 · Cited by 97
CDK11p58 is required for the maintenance of sister chromatid cohesion
Hu, D., Valentine, M. B., Kidd, V. J., & Lahti, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.007963 · Cited by 96
Activation by c-Myc of transcription by RNA polymerases I, II and III
Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., Ramsbottom, B. A., Innes, F., Kantidakis, T., Kerr, E. R., et al. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730141 · Cited by 95
Arabi, A., Rustum, C., Hallberg, E., & Wright, A. P. H. (2003) · Journal of Cell Science · doi:10.1242/jcs.00370 · Cited by 94
Barkić, M., Crnomarković, S., Grabušić, K., Bogetić, I., Panić, L., Tamarut, S., Brdovčak, M. C., Jerić, I., Vidak, S., & Volarević, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01588-08 · Cited by 92
Tinton, S. A., Schepens, B., Bruynooghe, Y., Beyaert, R., & Cornelis, S. (2004) · Biochemical Journal · doi:10.1042/bj20040963 · Cited by 87
A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors
Schuldiner, O., & Benvenisty, N. (2001) · Oncogene · doi:10.1038/sj.onc.1204459 · Cited by 67
Schorl, C., & Sedivy, J. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0649 · Cited by 52
Boring, L. F., Sinervo, B., & Schubiger, G. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90231-5 · Cited by 22
Piedra, M., Delgado, M. D., Ros, M. A., & León, J. (2002) · PubMed · Cited by 22
Cited by
Sorted by citations
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,543
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,435
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
Activation of mTORC2 by Association with the Ribosome
Zinzalla, V., Stracka, D., Oppliger, W., & Hall, M. N. (2011) · Cell · doi:10.1016/j.cell.2011.02.014 · Cited by 648
Metadata
- Authors
- Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Ruggero, Davide
- ORCID
- Ruggero, Davide
- Venue
- Cancer Research
- Published
- 2009-11-30
- Volume
- 69
- Issue
- 23
- Pages
- 8839-8843
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2880919
- OpenAlex
- W2093199938
- Cited by
- 186
- References
- 42
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 18 · 2013: 13 · 2012: 19
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sandler Foundation
- National Institutes of Health (NIH-R01)
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL085572)
- National Cancer Institute (R01CA140456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- MYC oncogene, translational regulation, protein synthesis, ribosomal proteins, translation initiation factors, ribosomal DNA, genomic instability, cell cycle progression, tumor initiation, translation machinery
- MeSH terms
- Animals, Humans, Neoplasms, Protein Biosynthesis, Gene Expression Regulation, Neoplastic, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review